International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-2 doi: 10.5281/zenodo.15161686
Original Research Article
Comparative Study Between Classical and Stapler Circumcision: A Prospective Randomized Clinical Trial
Published
April 3, 2025
Abstract

Background: Circumcision remains one of the most commonly performed surgical procedures worldwide. Traditional methods involve manual excision and suturing, while newer stapler techniques offer potential advantages. This study aimed to compare outcomes between classical and stapler circumcision techniques.

Methods: A prospective randomized controlled trial was conducted with 50 male patients (age range: infants to adults) randomly assigned to either classical circumcision (Group A, n=25) or stapler circumcision (Group B, n=25). Primary outcomes measured included operative time, post-operative pain using Visual Analog Scale (VAS), complication rates, and recovery time. Patients were followed up at 1 and 2 weeks post-surgery.

Results: Stapler circumcision demonstrated significantly shorter operative times compared to classical technique (12 ± 2.5 minutes vs. 37 ± 7.5 minutes, p<0.001). Mean pain scores at 24 hours (4.0 ± 0.8 vs. 6.0 ± 1.2, p<0.001) and 48 hours (2.0 ± 0.6 vs. 4.0 ± 0.9, p<0.001) were significantly lower in the stapler group. Complication rates were higher in the classical group (40% vs. 12%, p=0.024), with swelling (20%), minor bleeding (12%), and infection (8%) being most common. Mean recovery time was shorter in the stapler group (7 ± 1 days vs. 11 ± 1 days, p<0.001).

Conclusion: Stapler circumcision offers significant advantages over classical techniques in terms of operative time, post-operative pain, complication rates, and recovery time. Despite higher procedural costs, these benefits may justify the use of stapler circumcision where resources permit.

 

Recommended Articles
Loading Image...
Volume-6, Issue-2
Citations
1881 Views
139 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved